Preclinical studies have shown that the administration of Dendritic cells transduced with the chemoattractant CCL21 can increase the infiltration of Dendritic cells, CD4+ and CD8+ T cells in the lung tumor microenvironment, thereby reducing tumor burden43. Here, CD4 is linked to neoplasm.